A MULTICENTRE randomised controlled trial has investigated how different inhaled corticosteroids (ICS) affect the airway microbiome in patients with severe chronic obstructive pulmonary disease (COPD).
A MULTICENTRE randomised controlled trial has investigated how different inhaled corticosteroids (ICS) affect the airway microbiome in patients with severe chronic obstructive pulmonary disease (COPD).